ZA200702075B - Therapeutic combinations comprising poly(ADP-ribose) polymerases inhibitor - Google Patents
Therapeutic combinations comprising poly(ADP-ribose) polymerases inhibitorInfo
- Publication number
- ZA200702075B ZA200702075B ZA200702075A ZA200702075A ZA200702075B ZA 200702075 B ZA200702075 B ZA 200702075B ZA 200702075 A ZA200702075 A ZA 200702075A ZA 200702075 A ZA200702075 A ZA 200702075A ZA 200702075 B ZA200702075 B ZA 200702075B
- Authority
- ZA
- South Africa
- Prior art keywords
- adp
- ribose
- poly
- therapeutic combinations
- polymerases
- Prior art date
Links
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US61245804P | 2004-09-22 | 2004-09-22 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200702075B true ZA200702075B (en) | 2009-04-29 |
Family
ID=40463720
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200702075A ZA200702075B (en) | 2004-09-22 | 2007-03-09 | Therapeutic combinations comprising poly(ADP-ribose) polymerases inhibitor |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN101384264B (en) |
ZA (1) | ZA200702075B (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK3150610T3 (en) * | 2010-02-12 | 2019-11-04 | Pfizer | SALTS AND POLYMORPHS OF 8-FLUORO-2- {4 - [(METHYLAMINO} METHYL] PHENYL} -1,3,4,5-TETRAHYDRO-6H-AZEPINO [5,4,3-CD] INDOL-6-ON |
US20210369681A1 (en) * | 2018-10-22 | 2021-12-02 | Yale University | Identification of PPM1D mutations as a novel biomarker for NAMPTi sensitivity |
-
2005
- 2005-09-09 CN CN2005800317699A patent/CN101384264B/en active Active
-
2007
- 2007-03-09 ZA ZA200702075A patent/ZA200702075B/en unknown
Also Published As
Publication number | Publication date |
---|---|
CN101384264B (en) | 2012-03-14 |
CN101384264A (en) | 2009-03-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL181681A0 (en) | Therapeutic combinations comprising poly(adp-ribose) polymerases inhibitor | |
ZA200604774B (en) | Substituted 6-cyclohexylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly (ADP-ribose) polymerase inhibitors | |
EP1729761A4 (en) | Cadasil treatment with cholinesterase inhibitors | |
IL219642A0 (en) | Catheter | |
GB2428141B (en) | Shelving | |
SG156643A1 (en) | One time password | |
EP1787673A4 (en) | Catheter | |
EP1789709A4 (en) | Stopcock | |
IL177155A0 (en) | Therapeutic combinations | |
SI1811990T1 (en) | Anti-demodicosis agent | |
GB0417481D0 (en) | Combination therapy | |
GB0428180D0 (en) | Combination therapy | |
GB0424339D0 (en) | Combination therapy | |
ZA200702075B (en) | Therapeutic combinations comprising poly(ADP-ribose) polymerases inhibitor | |
GB0426141D0 (en) | Treatment | |
GB0410817D0 (en) | Vascular damaging therapy | |
GB0421136D0 (en) | Sequences | |
GB0425059D0 (en) | Restrictor | |
GB0421436D0 (en) | Combination therapy | |
GB0421438D0 (en) | Combination therapy | |
GB0400310D0 (en) | Anti-incrustation agent | |
GB0408959D0 (en) | Therapeutic agent | |
GB0406450D0 (en) | Combination therapy | |
GB0407755D0 (en) | Combination therapy | |
GB0406546D0 (en) | Combination therapy |